Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 187.90
-2.15 (-1.13%)
At close: Dec 4, 2025
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
14.84M INR
Profits / Employee
1.91M INR
Market Cap
83.37B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,840 | 699 | 61.26% |
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Marksans Pharma News
- 18 days ago - Marksans Pharma gets final USFDA approval for Loperamide Hydrochloride Tablets - Business Upturn
- 19 days ago - Marksans Pharma Ltd (BOM:524404) Q2 2026 Earnings Call Highlights: Strong US Growth and ... - GuruFocus
- 19 days ago - Q2 2026 Marksans Pharma Ltd Earnings Call Transcript - GuruFocus
- 20 days ago - Marksans Pharma secures UK MHRA approval for 250 mg and 500 mg Mefenamic Acid - Business Upturn
- 27 days ago - Marksans Pharma’s Goa facility clears US FDA inspection with zero observations - Business Upturn
- 4 weeks ago - Marksans Pharma shares rise after UK MHRA approval for cancer drug Exemestane 25mg tablets - Business Upturn
- 4 weeks ago - Marksans Pharma’s UK subsidiary Relonchem gets MHRA approval for Exemestane 25mg Tablets - Business Upturn
- 7 weeks ago - Marksans Pharma’s UK subsidiary Relonchem secures MHRA approval for two products - Business Upturn